Shares of Global Health gained 2.27% to trade at Rs 1,353.10 in Monday's session. At 10:16 am, the stock showcased positive movement, reflecting very bullish investor sentiment.
Financial Snapshot
The following table summarizes the key financial performance indicators for Global Health:
| Financial Year | Revenue (Rs. Crore) | Net Profit (Rs. Crore) | EPS (Rs.) | BVPS (Rs.) | ROE (%) | Debt to Equity |
|---|---|---|---|---|---|---|
| 2022 | 2,166.59 | 196.20 | 7.78 | 63.82 | 12.14 | 0.52 |
| 2023 | 2,694.25 | 326.08 | 12.58 | 90.54 | 13.42 | 0.35 |
| 2024 | 3,275.11 | 478.06 | 17.80 | 108.21 | 16.45 | 0.14 |
| 2025 | 3,692.32 | 481.32 | 17.92 | 126.08 | 14.21 | 0.10 |
The company has demonstrated consistent growth in revenue and net profit over the past four years. Revenue increased from Rs 2,166.59 Crore in 2022 to Rs 3,692.32 Crore in 2025. Net profit also rose from Rs 196.20 Crore in 2022 to Rs 481.32 Crore in 2025.
Quarterly Performance
A look at the consolidated quarterly results provides the following details:
| Quarter | Revenue (Rs. Crore) | Net Profit (Rs. Crore) | EPS (Rs.) |
|---|---|---|---|
| Mar 2024 | 808.63 | 127.35 | 4.74 |
| Jun 2024 | 861.08 | 106.26 | 3.96 |
| Sep 2024 | 956.56 | 130.82 | 4.87 |
| Dec 2024 | 943.44 | 142.86 | 5.32 |
| Mar 2025 | 931.25 | 101.38 | 3.77 |
The revenue for the quarter ending March 2025 was Rs 931.25 Crore, while the net profit stood at Rs 101.38 Crore. The earnings per share (EPS) for the same period was Rs 3.77.
Standalone Income Statement (Annual)
| Particulars | Mar 2025 (Rs. Crore) | Mar 2024 (Rs. Crore) | Mar 2023 (Rs. Crore) |
|---|---|---|---|
| Sales | 3,204 | 2,280 | 1,959 |
| Other Income | 90 | 102 | 61 |
| Total Income | 3,295 | 2,382 | 2,021 |
| Total Expenditure | 2,638 | 1,869 | 1,643 |
| EBIT | 656 | 513 | 377 |
| Interest | 33 | 24 | 26 |
| Tax | 161 | 127 | 88 |
| Net Profit | 461 | 360 | 263 |
The annual standalone financials show consistent growth with sales increasing to Rs 3,204 Crore in March 2025 from Rs 1,959 Crore in March 2023.
Standalone Income Statement (Quarterly)
| Particulars | Mar 2025 (Rs. Crore) | Dec 2024 (Rs. Crore) | Sep 2024 (Rs. Crore) | Jun 2024 (Rs. Crore) | Mar 2024 (Rs. Crore) |
|---|---|---|---|---|---|
| Sales | 802 | 624 | 664 | 611 | 578 |
| Other Income | 25 | 22 | 23 | 26 | 32 |
| Total Income | 828 | 646 | 688 | 638 | 611 |
| Total Expenditure | 695 | 508 | 539 | 502 | 479 |
| EBIT | 132 | 138 | 148 | 135 | 131 |
| Interest | 7 | 5 | 5 | 5 | 6 |
| Tax | 32 | 33 | 39 | 33 | 32 |
| Net Profit | 93 | 99 | 104 | 96 | 92 |
The quarterly standalone financials show sales of Rs 802 Crore for March 2025, compared to Rs 578 Crore in March 2024.
Cash Flow (Standalone)
| Particulars | Mar 2025 (Rs. Crore) | Mar 2024 (Rs. Crore) | Mar 2023 (Rs. Crore) |
|---|---|---|---|
| Operating Activities | 527 | 340 | 430 |
| Investing Activities | -638 | -698 | -257 |
| Financing Activities | -94 | -66 | 404 |
| Others | 0 | 0 | 0 |
| Net Cash Flow | -205 | -424 | 577 |
The cash flow statement indicates that net cash flow was negative at Rs -205 Crore in March 2025 compared to Rs 577 Crore in March 2023.
Balance Sheet (Standalone)
| Particulars | Mar 2025 (Rs. Crore) | Mar 2024 (Rs. Crore) | Mar 2023 (Rs. Crore) |
|---|---|---|---|
| Share Capital | 53 | 53 | 53 |
| Reserves & Surplus | 3,443 | 2,795 | 2,435 |
| Current Liabilities | 518 | 419 | 396 |
| Other Liabilities | 424 | 254 | 293 |
| Total Liabilities | 4,440 | 3,523 | 3,178 |
| Fixed Assets | 1,928 | 1,025 | 884 |
| Current Assets | 1,452 | 1,290 | 1,397 |
| Other Assets | 1,058 | 1,207 | 895 |
| Total Assets | 4,440 | 3,523 | 3,178 |
| Contingent Liabilities | 0 | 300 | 241 |
Total assets increased from Rs 3,178 Crore in March 2023 to Rs 4,440 Crore in March 2025.
Financial Ratios (Standalone)
| Ratio | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Basic EPS (Rs.) | 17.18 | 13.44 | 10.16 |
| Diluted Eps (Rs.) | 17.18 | 13.44 | 10.15 |
| Book Value /Share (Rs.) | 130.22 | 106.10 | 92.80 |
| Dividend/Share (Rs.) | 0.50 | 0.00 | 0.00 |
| Face Value | 2 | 2 | 2 |
| Gross Profit Margin (%) | 26.71 | 26.32 | 23.67 |
| Operating Margin (%) | 22.04 | 22.50 | 19.28 |
| Net Profit Margin (%) | 14.40 | 15.82 | 13.43 |
| Return on Networth (%) | 13.19 | 12.66 | 10.57 |
| ROCE (%) | 18.01 | 16.53 | 13.58 |
| Return On Assets (%) | 10.39 | 10.24 | 8.28 |
| Current Ratio (X) | 2.80 | 3.08 | 3.52 |
| Quick Ratio (X) | 2.71 | 2.97 | 3.42 |
| Debt to Equity (x) | 0.04 | 0.02 | 0.04 |
| Interest Coverage (X) | 25.63 | 24.54 | 17.73 |
| Asset Turnover (%) | 0.80 | 0.68 | 0.71 |
| Inventory Turnover (X) | 15.35 | 11.71 | 10.46 |
| 3 Yr CAGR Sales (%) | 5,560.52 | 4,674.95 | 4,326.57 |
| 3 Yr CAGR Net Profit (%) | 2,048.32 | 1,799.71 | 1,522.50 |
| P/E (x) | 69.75 | 98.30 | 51.87 |
| P/B (x) | 9.20 | 12.48 | 5.67 |
| EV/EBITDA (x) | 36.53 | 57.72 | 28.17 |
| P/S (x) | 10.04 | 15.59 | 7.20 |
The P/E ratio as of March 2025 stood at 69.75, while the P/B ratio was 9.20.
Corporate Actions
Global Health Limited announced the allotment of equity shares under the Global Health Limited Long Term Share Based Incentive Plan 2024, as per Regulation 30 of the Listing Regulations on July 24, 2025. Also, the company provided an update on earlier communications regarding Assam Land.
The company announced a final dividend of Rs 0.50 per share (25%) on May 15, 2025.
With the stock currently trading at Rs 1,353.10, Global Health shows positive momentum in today's session, reflecting very bullish sentiment.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
